Latest ARCH VENTURE CORP Stock Portfolio
$80.28Million– No. of Holdings #8
ARCH VENTURE CORP Performance:
2024 Q1: -0.55%YTD: -0.55%2023: -6.57%
Performance for 2024 Q1 is -0.55%, and YTD is -0.55%, and 2023 is -6.57%.
About ARCH VENTURE CORP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $80.3 Millions as of 31 Mar, 2024.
The top stock holdings of ARCH Venture Management, LLC are VERV, ERAS, GOSS. The fund has invested 33.2% of it's portfolio in VERVE THERAPEUTICS, INC. and 28.4% of portfolio in ERASCA, INC.
The fund managers got completely rid off REVOLUTION MEDICINES, INC. (RVMD) stocks. ARCH Venture Management, LLC opened new stock positions in Q32 BIO INC. and CERO THERAPEUTICS HOLDINGS, INC. (PBAX).
The top stock holdings of ARCH Venture Management, LLC are VERV, ERAS, GOSS. The fund has invested 33.2% of it's portfolio in VERVE THERAPEUTICS, INC. and 28.4% of portfolio in ERASCA, INC.
The fund managers got completely rid off REVOLUTION MEDICINES, INC. (RVMD) stocks. ARCH Venture Management, LLC opened new stock positions in Q32 BIO INC. and CERO THERAPEUTICS HOLDINGS, INC. (PBAX).
ARCH VENTURE CORP Equity Portfolio Value
Last Reported on: 15 May, 2024
ARCH VENTURE CORP Annual Return Estimates Vs S&P 500
Our best estimate is that ARCH Venture Management, LLC made a return of -0.55% in the last quarter. In trailing 12 months, it's portfolio return was 9.14%.
New Buys
| Ticker | $ Bought |
|---|---|
| q32 bio inc. | 5,461,010 |
| cero therapeutics holdings, inc. | 4,433,990 |
New stocks bought by ARCH VENTURE CORP
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| revolution medicines, inc. | -92,736,500 |
ARCH VENTURE CORP got rid off the above stocks
Sector Distribution
ARCH Venture Management, LLC has about 87.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.7 |
| Others | 12.3 |
Market Cap. Distribution
ARCH Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 61.6 |
| UNALLOCATED | 12.3 |
| MICRO-CAP | 11.8 |
| MID-CAP | 9.7 |
| NANO-CAP | 4.5 |
Stocks belong to which Index?
About 71.3% of the stocks held by ARCH Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 71.3 |
| Others | 28.7 |
ARCH VENTURE CORP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ARCH VENTURE CORP
ARCH Venture Management, LLC has 8 stocks in it's portfolio. VERV proved to be the most loss making stock for the portfolio. GOSS was the most profitable stock for ARCH Venture Management, LLC last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| DNLI | denali therapeutics, inc. | 9.74 | 381,249 | 7,823,230 | unchanged | 0.00 | ||
| ERAS | erasca, inc. | 28.37 | 11,055,600 | 22,774,400 | unchanged | 0.00 | ||
| GOSS | gossamer bio, inc. | 11.84 | 8,055,920 | 9,505,980 | unchanged | 0.00 | ||
| OMIC | singular genomics systems, inc. | 2.43 | 3,798,930 | 1,953,410 | unchanged | 0.00 | ||
| PBAX | cero therapeutics holdings, inc. | 5.52 | 1,444,300 | 4,433,990 | new | |||
| RVMD | revolution medicines, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| UBX | unity biotechnology, inc. | 2.05 | 1,004,820 | 1,647,900 | unchanged | 0.00 | ||
| VERV | verve therapeutics, inc. | 33.23 | 2,008,810 | 26,677,000 | unchanged | 0.00 | ||
| q32 bio inc. | 6.80 | 320,482 | 5,461,010 | new | ||||